Results 71 to 80 of about 17,658 (183)
The results of aflibercept therapy as a first line treatment of age-related macular degeneration
Journal of Current Ophthalmology, 2019 Purpose: To report the results of aflibercept treatment in treatment-naive neovascular age-related macular degeneration (AMD) patients and suggest a suitable treatment algorithm for routine clinical practice.
Erkan Unsal, Mehmet Ozgur Cubuk
doaj +1 more source
Diabetes, Obesity and Metabolism, Volume 28, Issue 8, Page 7580-7591, August 2026.ABSTRACT Aims To assess whether glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) are associated with a lower incidence of age‐related ocular diseases in non‐diabetic older adults with overweight or obesity. Materials and Methods We conducted a retrospective, propensity score–matched cohort study using the TriNetX global research network.
Kuo‐En Chen +3 more
wiley +1 more source
Effects of Vitreomacular Adhesion on Age-Related Macular Degeneration
Journal of Ophthalmology, 2015 Herein, we review the association between vitreomacular adhesion (VMA) and neovascular age-related macular degeneration (AMD). Meta-analyses have shown that eyes with neovascular AMD are twice as likely to have VMA as normal eyes.
Eui Chun Kang, Hyoung Jun Koh
doaj +1 more source
Current perspectives on ranibizumab
Clinical Ophthalmology, 2015 Vaidehi S Dedania,1 Sophie J Bakri21Department of Ophthalmology, Albany Medical Center, Lions Eye Institute, Albany, NY, USA; 2Department of Ophthalmology, Mayo Clinic, Rochester, MN, USABackground: This review summarizes the Phase III studies addressing
Dedania VS, Bakri SJ
doaj
Treatment of neovascular age-related macular degeneration: Current therapies
Clinical Ophthalmology, 2009 Albert J Augustin, Stefan Scholl, Janna KirchhofDepartment of Ophthalmology, Klinikum Karlsruhe, GermanyAbstract: Choroidal neovascularization (CNV) secondary to age-related macular degeneration (AMD) is now the leading cause of blindness and severe ...
Albert J Augustin +2 more
doaj
Treatment of neovascular age-related macular degeneration in patients with diabetes
Clinical Ophthalmology, 2008 Michael Cummings1, José Cunha-Vaz21Academic Department of Diabetes and Endocrinology, Queen Alexandra Hospital, Portsmouth, UK; 2Department of Ophthalmology, University Hospital of Coimbra, Centre of Ophthalmology, Institute of Biomedical ...
Michael Cummings +1 more
doaj
Long-Term Follow-Up of Dry Age-Related Macular Degeneration Patients
Journal of Current OphthalmologyPurpose: To assess the progression rate from dry age-related macular degeneration (dAMD) to advanced AMD and possible risk factors. Methods: Demographics, medical and ocular conditions, baseline eye examinations, optical coherence tomography features ...
Elham Sadeghi +8 more
doaj +1 more source
Clinical Ophthalmology, 2022 Jeffrey K Luttrull,1 Gerry Gray2 1Ventura County Retina Vitreous Medical Group, Ventura, CA, USA; 2Regulatory Pathways, Inc, Laguna Beach, CA, USACorrespondence: Jeffrey K Luttrull, Ventura County Retina Vitreous Medical Group, 3160 Telegraph Road, Suite
Luttrull JK, Gray G
doaj
Neovascular Age-related Macular Degeneration
, 2022 This thesis describes the treatment of exudative Age-Related Macular Degeneration (ARMD) with bevacizumab. The main object of the thesis was to evaluate the viability of less frequent bevacizumab dosage regiments. Furthermore, the reactivation interval of CNV was observed, and we delved deeper into a specific kind of CNV and its characteristics using a
openaire +1 more source
Clinical Ophthalmology, 2013 Yousif Subhi, Amardeep Singh, Mads Krüger Falk, Torben Lykke SørensenDepartment of Ophthalmology, Clinical Eye Research Unit, Copenhagen University Hospital Roskilde and the University of Copenhagen, Copenhagen, DenmarkPurpose: Association of
Subhi Y +3 more
doaj